A substrate-specific mTORC1 pathway underlies Birt-Hogg-Dubé syndrome.
What this study shows
A substrate-specific mTORC1-TFEB pathway (RagC/D-dependent) drives Birt-Hogg-Dube kidney disease.
At a glance
| Evidence type | M Molecular — cells, biochemistry, structure Marked M because it is molecular or in-vitro work (model: Human cells; mouse) rather than a whole-organism health-outcome study. That is often exactly where causal biology gets established -- the code says which system the finding was shown in, and nothing about how good the work is. |
| Study type | 5 - Mechanistic / In Vitro |
| Model system | Human cells; mouse |
| Journal | Nature |
| Year | 2020 |
| Peer reviewed | Yes |
| Record last updated | 2026-10-01 |
| Source | DOI 10.1038/s41586-020-2444-0 · PMID 32612235 · Free full text (PMC7610377) |
Extracted findings
These fields were extracted from the paper with AI assistance and have not been checked against the source. Read them as a pointer into the paper, not as curated claims; where they disagree with the curated summary above, the curated summary stands.
| Intervention | Genetic (FLCN / mTORC1) |
| Target | mTORC1 / TFEB / FLCN |
| Model | Human cells; mouse |
| Effect | A substrate-specific mTORC1 pathway phosphorylates TFEB and underlies Birt-Hogg-Dubé syndrome |
In the Atlas
Links in the pathway map
- Supports FLCN / FNIP1/2 activates Rag GTPases
Was this page useful?
Thank you. Your answer was counted anonymously.